These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 24064755

  • 1. Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.
    Pelizzo MR, Torresan F, Boschin IM, Nacamulli D, Pennelli G, Barollo S, Rubello D, Mian C.
    Am J Clin Oncol; 2015 Oct; 38(5):508-13. PubMed ID: 24064755
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).
    Niederle B, Sebag F, Brauckhoff M.
    Langenbecks Arch Surg; 2014 Feb; 399(2):185-97. PubMed ID: 24297502
    [Abstract] [Full Text] [Related]

  • 5. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
    de Groot JW, Links TP, Rouwe CW, van der Wal JE, Hofstra RM, Plukker JT.
    Ned Tijdschr Geneeskd; 2006 Feb 11; 150(6):311-8. PubMed ID: 16503023
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing.
    Lau GS, Lang BH, Lo CY, Tso A, Garcia-Barcelo MM, Tam PK, Lam KS.
    Hong Kong Med J; 2009 Oct 11; 15(5):326-31. PubMed ID: 19801688
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [30 years of prophylactic thyroidectomy for hereditary medullary thyroid cancer : A milestone in translational medicine].
    Dralle H, Weber F, Lorenz K, Machens A.
    Chirurgie (Heidelb); 2024 Aug 11; 95(8):638-650. PubMed ID: 38806713
    [Abstract] [Full Text] [Related]

  • 12. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
    Skinner MA, DeBenedetti MK, Moley JF, Norton JA, Wells SA.
    J Pediatr Surg; 1996 Jan 11; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
    [Abstract] [Full Text] [Related]

  • 13. Current understanding and management of medullary thyroid cancer.
    Roy M, Chen H, Sippel RS.
    Oncologist; 2013 Jan 11; 18(10):1093-100. PubMed ID: 24037980
    [Abstract] [Full Text] [Related]

  • 14. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
    Elisei R, Bottici V, Cappagli V, Ramone T, Tacito A, Ciampi R, Romei C.
    Ann Endocrinol (Paris); 2019 Jun 11; 80(3):187-190. PubMed ID: 31053251
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia.
    Colombo-Benkmann M, Brämswig J, Höppner W, Gellner R, Hengst K, Böcker W, Senninger N.
    World J Surg; 2002 Oct 11; 26(10):1286-90. PubMed ID: 12205548
    [Abstract] [Full Text] [Related]

  • 18. Germline RET mutation carriers in Japanese patients with apparently sporadic medullary thyroid carcinoma: A single institution experience.
    Kihara M, Miyauchi A, Yoshioka K, Oda H, Nakayama A, Sasai H, Yabuta T, Masuoka H, Higashiyama T, Fukushima M, Ito Y, Kobayashi K, Miya A.
    Auris Nasus Larynx; 2016 Oct 11; 43(5):551-5. PubMed ID: 26837867
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE, Domene HM, Garcia R, Pusiol E, de M, Roque M, Ring A, Perinetti H, Elsner B, Iorcansky S, Barontini M.
    Cancer; 2002 Jan 15; 94(2):323-30. PubMed ID: 11900218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.